101 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 19838098 | Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial. | 2010 Jan 2 | 3 |
52 | 20130569 | ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. | 2010 May | 3 |
53 | 20195400 | Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia. | 2010 Mar | 1 |
54 | 20335146 | [Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation]. | 2010 Mar | 3 |
55 | 20679960 | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 2010 Oct | 1 |
56 | 20953684 | Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study. | 2010 Dec | 1 |
57 | 21090830 | The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. | 2010 | 2 |
58 | 21090831 | Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels. | 2010 | 3 |
59 | 21122696 | Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. | 2010 Nov-Dec | 2 |
60 | 22291492 | A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy. | 2010 | 1 |
61 | 18996523 | Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study. | 2009 May | 2 |
62 | 19174696 | Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin. | 2009 Apr | 1 |
63 | 19729865 | Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia. | 2009 Aug | 5 |
64 | 19745745 | A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. | 2009 Dec | 2 |
65 | 19916726 | Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice. | 2009 Dec | 8 |
66 | 19997842 | [Achievement of blood lipid target levels with Ezetimibe/Simvastatin in patients with atherosclerosis and/or diabetes mellitus--an Austrian observational study]. | 2009 | 1 |
67 | 23555375 | A Randomized Controlled Study to Compare the Effects of Rosuvastatin 2.5 mg and Pravastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-1). | 2009 | 3 |
68 | 23555376 | A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2). | 2009 | 2 |
69 | 18364261 | Efficacy and safety of rosuvastatin in Taiwanese patients. | 2008 Mar | 1 |
70 | 18434729 | Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. | 2008 | 4 |
71 | 18489494 | Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. | 2008 Dec | 4 |
72 | 18578957 | LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. | 2008 Aug | 2 |
73 | 18654867 | Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. | 2008 Jul 26 | 1 |
74 | 18690760 | Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. | 2008 | 4 |
75 | 21291725 | Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses. | 2008 Apr | 4 |
76 | 21291777 | Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. | 2008 Dec | 1 |
77 | 17484092 | [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]. | 2007 Apr | 3 |
78 | 17655813 | Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. | 2007 Sep | 7 |
79 | 17996658 | Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. | 2007 Sep | 5 |
80 | 18158079 | Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. | 2007 Nov | 5 |
81 | 21291692 | Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia. | 2007 Aug | 2 |
82 | 16533939 | Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. | 2006 Apr 5 | 1 |
83 | 16644314 | Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. | 2006 May | 3 |
84 | 17112329 | Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. | 2006 Nov | 4 |
85 | 17212997 | Expanding options with a wider range of rosuvastatin doses. | 2006 Nov | 3 |
86 | 15707472 | Review of efficacy of rosuvastatin 5 mg. | 2005 Jan | 4 |
87 | 16128507 | Rosuvastatin: a high-potency HMG-CoA reductase inhibitor. | 2005 Jul-Aug | 2 |
88 | 16143705 | A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. | 2005 Dec | 4 |
89 | 16186052 | Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals. | 2005 Oct 10 | 6 |
90 | 15161326 | Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. | 2004 | 2 |
91 | 15215813 | Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. | 2004 Jul | 5 |
92 | 15531000 | Rosuvastatin in the management of hyperlipidemia. | 2004 Sep | 6 |
93 | 15639694 | Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. | 2004 Nov | 4 |
94 | 16035394 | A review of the efficacy of rosuvastatin in patients with type 2 diabetes. | 2004 Oct | 3 |
95 | 19667621 | New evidence supporting aggressive lipid lowering. | 2003 Apr | 1 |
96 | 11900720 | Managing dyslipidemia in the high-risk patient. | 2002 Mar 7 | 2 |
97 | 12137448 | Statin therapy: rationale for a new agent, rosuvastatin. | 2002 Jun | 3 |
98 | 12238638 | Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. | 2002 | 1 |
99 | 12486415 | Management of dyslipidemia in the high-risk patient. | 2002 Dec | 2 |
100 | 11256849 | Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin. | 2001 Mar 8 | 2 |